BIOMAT Database Logo BIOMAT Database Logo

Visceral leishmaniasis in a renal transplant recipient treated with allopurinol. 2010

Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Unity of Organ Transplantation, Military Hospital, Tunis, Tunisia. harzallakais@yahoo.fr

Leishmaniasis is an infection caused by a protozoan parasite belonging to the genus Leishmania and transmitted by the Phlebotomus sandfly. We report a case of visceral leishmaniasis in a 49-year-old male renal transplant recipient, a resident of the western part of Tunisia, which is an endemic zone for the disease. Just before and after the transplantation, the patient resided in Tunis, which is non-endemic for leishmaniasis. Visceral leishmaniasis occurred eight years after renal transplantation, and the clinical picture was characterized by fever and pancytopenia. Leishmaniae were detected by bone marrow aspiration. Pentavalent antimonal was used for 28 days and was substituted by allopurinol (20 mg/kg per day). One year after the infection, the patient remains totally asymptomatic. Our report suggests that visceral leishmaniasis may complicate the clinical course of organ transplantation and can be fatal, particularly when untreated. Relapses may occur after completion of the apparently effective treatment. Allopurinol could be a solution to avoid these relapses.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008297 Male Males
D008536 Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Methylglucamine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D001856 Bone Marrow Examination Removal of bone marrow and evaluation of its histologic picture. Examination, Bone Marrow,Bone Marrow Examinations,Examinations, Bone Marrow
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077485 Meglumine Antimoniate ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS. Glucantime,N-Methylglucamine Antimonate,N Methylglucamine Antimonate
D000493 Allopurinol A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. Allohexal,Allohexan,Alloprin,Allopurin,Allorin,Allpargin,Allural,Apulonga,Apurin,Atisuril,Bleminol,Caplenal,Capurate,Cellidrin,Embarin,Foligan,Hamarin,Jenapurinol,Lopurin,Lysuron,Milurit,Milurite,Novopurol,Pan Quimica,Progout,Pureduct,Purinol,Remid,Rimapurinol,Roucol,Suspendol,Tipuric,Uribenz,Uridocid,Uripurinol,Urosin,Urtias,Xanthomax,Xanturic,Zygout,Zyloprim,Zyloric

Related Publications

Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Visceral leishmaniasis with cutaneous dissemination in a renal transplant recipient.
January 2013, European journal of dermatology : EJD,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole.
January 2013, Annals of Saudi medicine,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
January 1996, American journal of nephrology,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Visceral leishmaniasis in a renal transplant recipient: a diagnostic and therapeutic challenge.
November 1986, The Journal of infection,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Visceral leishmaniasis: an unusual case of fever in a renal transplant recipient.
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative.
January 1998, American journal of nephrology,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Fatal visceral leishmaniasis in a heart transplant recipient.
August 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.
March 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Visceral leishmaniasis without fever in a kidney transplant recipient.
January 1997, Nephron,
Kais Harzallah, and Raoudha Belhadj, and Boutheina Jemli, and Mondher Haloues, and Naoufel Berraies, and Saadia Gargouri, and Jalel Hmida, and Riadh Battikh, and Jamel Manaa
Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure.
September 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!